{"id":"W4385302690","doi":"10.1038/s41591-023-02452-y","title":"Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Mesothelin; Medicine; Internal medicine; Pneumonitis; Interim analysis; Pembrolizumab; Oncology; Cytokine release syndrome; Clinical endpoint; Refractory (planetary science); Gastroenterology; Cancer; Clinical trial; Chimeric antigen receptor; Immunotherapy; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002408781,0.001228811,0.001284204,0.0002627216,0.0003824315,0.001098887,0.0006107381,0.00168338,0.00251979],"category_scores_gemma":[0.0008521818,0.0002778728,0.0008762688,0.0001807373,0.000562686,0.0006886111,0.0002759839,0.001955764,0.0007405599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005560035,"about_ca_system_score_gemma":0.00109679,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004983993,"about_ca_topic_score_gemma":0.001099691,"domain_scores_codex":[0.9995525,0.0002003908,0.00002243602,0.00004653158,0.00006341108,0.0001147174],"domain_scores_gemma":[0.9994629,0.0001237141,0.00009103561,0.00004737201,0.00005042869,0.0002246176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4074588,0.0588406,0.01440708,0.002447759,0.002038301,0.002007565,0.0009234366,0.009969996,0.2382058,0.001917144,0.03972545,0.2220581],"study_design_scores_gemma":[0.3394327,0.5868815,0.01839442,0.0001492905,0.0005985662,0.001077731,0.0001075781,0.005811758,0.02821979,0.0009686375,0.01829672,0.00006133396],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.975897,0.003857511,0.003053187,0.001951513,0.0003266674,0.005618799,0.004520027,0.000368818,0.004406584],"genre_scores_gemma":[0.9680811,0.002638554,0.004483839,0.002526053,0.000313442,0.007247312,0.0076167,0.0001031986,0.006989823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00251979,"threshold_uncertainty_score":0.01273906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03486724585317036,"score_gpt":0.3866904057862175,"score_spread":0.3518231599330471,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}